Literature DB >> 20847294

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Les Dethlefsen1, David A Relman.   

Abstract

The indigenous human microbiota is essential to the health of the host. Although the microbiota can be affected by many features of modern life, we know little about its responses to disturbance, especially repeated disturbances, and how these changes compare with baseline temporal variation. We examined the distal gut microbiota of three individuals over 10 mo that spanned two courses of the antibiotic ciprofloxacin, analyzing more than 1.7 million bacterial 16S rRNA hypervariable region sequences from 52 to 56 samples per subject. Interindividual variation was the major source of variability between samples. Day-to-day temporal variability was evident but constrained around an average community composition that was stable over several months in the absence of deliberate perturbation. The effect of ciprofloxacin on the gut microbiota was profound and rapid, with a loss of diversity and a shift in community composition occurring within 3-4 d of drug initiation. By 1 wk after the end of each course, communities began to return to their initial state, but the return was often incomplete. Although broadly similar, community changes after ciprofloxacin varied among subjects and between the two courses within subjects. In all subjects, the composition of the gut microbiota stabilized by the end of the experiment but was altered from its initial state. As with other ecosystems, the human distal gut microbiome at baseline is a dynamic regimen with a stable average state. Antibiotic perturbation may cause a shift to an alternative stable state, the full consequences of which remain unknown.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20847294      PMCID: PMC3063582          DOI: 10.1073/pnas.1000087107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea.

Authors:  Laurent Beaugerie; Jean-Claude Petit
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-04       Impact factor: 3.043

Review 2.  The evolution of cooperation.

Authors:  Joel L Sachs; Ulrich G Mueller; Thomas P Wilcox; James J Bull
Journal:  Q Rev Biol       Date:  2004-06       Impact factor: 4.875

Review 3.  Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.

Authors:  Alain L Servin
Journal:  FEMS Microbiol Rev       Date:  2004-10       Impact factor: 16.408

4.  Partitioning diversity into independent alpha and beta components.

Authors:  Lou Jost
Journal:  Ecology       Date:  2007-10       Impact factor: 5.499

Review 5.  Bile salt biotransformations by human intestinal bacteria.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2005-11-18       Impact factor: 5.922

6.  Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells.

Authors:  Isabelle Ingrassia; Antony Leplingard; Arlette Darfeuille-Michaud
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

7.  Allergic disease and sensitization in Steiner school children.

Authors:  Helen Flöistrup; Jackie Swartz; Anna Bergström; Johan S Alm; Annika Scheynius; Marianne van Hage; Marco Waser; Charlotte Braun-Fahrländer; Dieneke Schram-Bijkerk; Machteld Huber; Anne Zutavern; Erika von Mutius; Ellen Ublagger; Josef Riedler; Karin B Michaels; Göran Pershagen
Journal:  J Allergy Clin Immunol       Date:  2005-11-28       Impact factor: 10.793

Review 8.  Human intestinal bacteria as reservoirs for antibiotic resistance genes.

Authors:  Abigail A Salyers; Anamika Gupta; Yanping Wang
Journal:  Trends Microbiol       Date:  2004-09       Impact factor: 17.079

9.  Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis.

Authors:  J A Peña; S Y Li; P H Wilson; S A Thibodeau; A J Szary; J Versalovic
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

10.  Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces.

Authors:  Sylvia H Duncan; Georgina L Hold; Adela Barcenilla; Colin S Stewart; Harry J Flint
Journal:  Int J Syst Evol Microbiol       Date:  2002-09       Impact factor: 2.747

View more
  846 in total

1.  A metagenome of a full-scale microbial community carrying out enhanced biological phosphorus removal.

Authors:  Mads Albertsen; Lea Benedicte Skov Hansen; Aaron Marc Saunders; Per Halkjær Nielsen; Kåre Lehmann Nielsen
Journal:  ISME J       Date:  2011-12-15       Impact factor: 10.302

2.  Efficacious outcome employing fecal bacteriotherapy in severe Crohn's colitis complicated by refractory Clostridium difficile infection.

Authors:  C A Duplessis; D You; M Johnson; A Speziale
Journal:  Infection       Date:  2011-12-08       Impact factor: 3.553

3.  Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome.

Authors:  David T Pride; Julia Salzman; Matthew Haynes; Forest Rohwer; Clara Davis-Long; Richard A White; Peter Loomer; Gary C Armitage; David A Relman
Journal:  ISME J       Date:  2011-12-08       Impact factor: 10.302

4.  Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations.

Authors:  Chenhong Zhang; Menghui Zhang; Xiaoyan Pang; Yufeng Zhao; Linghua Wang; Liping Zhao
Journal:  ISME J       Date:  2012-04-12       Impact factor: 10.302

Review 5.  The human microbiome and its potential importance to pediatrics.

Authors:  Coreen L Johnson; James Versalovic
Journal:  Pediatrics       Date:  2012-04-02       Impact factor: 7.124

Review 6.  Inference of functional properties from large-scale analysis of enzyme superfamilies.

Authors:  Shoshana D Brown; Patricia C Babbitt
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

7.  The optimal deployment of synergistic antibiotics: a control-theoretic approach.

Authors:  Rafael Peña-Miller; David Lähnemann; Hinrich Schulenburg; Martin Ackermann; Robert Beardmore
Journal:  J R Soc Interface       Date:  2012-05-23       Impact factor: 4.118

8.  Microbiology: The new germ theory.

Authors:  Lizzie Buchen
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

Review 9.  Mechanisms of weight loss and improved metabolism following bariatric surgery.

Authors:  Christopher M Mulla; Roeland J W Middelbeek; Mary-Elizabeth Patti
Journal:  Ann N Y Acad Sci       Date:  2017-09-03       Impact factor: 5.691

Review 10.  Microbiota and metabolic diseases.

Authors:  Alessia Pascale; Nicoletta Marchesi; Cristina Marelli; Adriana Coppola; Livio Luzi; Stefano Govoni; Andrea Giustina; Carmine Gazzaruso
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.